AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,560
-390 (-2.17%)
At close: Jul 11, 2025, 3:30 PM KST
-14.13%
Market Cap 395.58B
Revenue (ttm) 29.69B
Net Income (ttm) 22.63B
Shares Out 22.53M
EPS (ttm) 1,022.72
PE Ratio 17.17
Forward PE 47.08
Dividend n/a
Ex-Dividend Date n/a
Volume 161,620
Average Volume 204,775
Open 17,960
Previous Close 17,950
Day's Range 17,500 - 17,970
52-Week Range 11,980 - 25,900
Beta 1.51
RSI 53.98
Earnings Date n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.